Responses
Clinical and epidemiological research
Extended report
Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial
Compose a Response to This Article
Other responses
No responses have been published for this article.